ILLUMINA, INC. ILMN
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2000-06-28
ILLUMINA, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Operating margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Net margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% |
| FCF margin | 21.4% | 16.2% | 6.3% | 2.3% | 7.4% |
| Return on assets | 12.8% | -19.4% | -11.5% | -35.9% | 5.0% |
| Return on equity | 31.2% | -51.5% | -20.2% | -66.7% | 7.1% |
| Current ratio | 2.08 | 1.78 | 1.66 | 1.28 | 2.48 |
| Revenue growth | -0.7% | -2.9% | -1.7% | 1.3% | 39.7% |
Source: SEC EDGAR filings · CIK 0001110803 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.